Details
Category: Volume 07 Issue 10 October 2019
Hits: 1245

Title: A study of Serum IgE levels and Absolute Eosinophil Count in COPD

Authors: K.A. Vivek, N. Vijayakumar, R. Umarani

 DOI: https://dx.doi.org/10.18535/jmscr/v7i10.118

Abstract

   

Aims and Objectives: To study the prevalence of elevated serum total IgE levels and Absolute Eosinophil Count in Chronic Obstructive Pulmonary Disease (COPD) patients and its relation with GOLD staging.

Methods: This study is a cross sectional study conducted on 50 inpatients presented with symptoms of COPD in the department of medicine in RMMCH during the period from September 2017 to October 2019. The studied group was divided according to the GOLD staging and compared in demographic data, clinical data, spirometric data, chest x-ray findings, serum total IgE levels and Absolute Eosinophil Count (AEC).

Results: Out of the 50 patients enrolled in our study 84 % (n=42) of patients were found to have elevated serum IgE levels, and 58% (n=29) of patients were found to have elevated AEC levels. On comparing the serum IgE levels and Absolute Eosinophil Count with GOLD staging, there is a strong positive correlation between serum IgE, Absolute Eosinophil Count and GOLD staging, as the GOLD staging increases, the IgE and AEC also increases in a direct and linear fashion in our study subjects.

Conclusion: There was a high prevalence of elevated serum IgE levels and AEC in COPD patients. The mean serum total IgE levels and AEC increases as the GOLD stage increases.

References

  1. ICMR-MRC Workshop. Building Indo-UK Collaboration in chronic diseases.2009:16.
  2. Salvi S, Agarwal A. India needs a national COPD prevention and Control program.J Assoc Physicians India. 2012;60(Suppl):5–7.
  3. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive airway disease: Current burden and future projections.Eur Resp J. 2006;27:397–412.
  4. Vedel-Krogh S1,2,3, Nielsen SF1,2,3, Lange P2,4,5, Vestbo J6, Nordestgaard BG1,2,3. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
  5. Netsanet ANegewo1,Vanessa M McDonald1–4 et al, Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD, International journal of COPD.
  6. Dave Singh, Umme Kolsum, Chris E et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics, European Respiratory Journal 2014.
  7. Vedel-Krogh S1,2,3, Nielsen SF1,2,3, Lange P2,4,5, Vestbo J6, Nordestgaard BG1,2,3. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
  8. Umme Kolsum, 1 Gavin C. Donaldson,2 Richa Singh,2 Bethan L. Barker, Blood and sputum eosinophils in COPD; relationship with bacterial load, ReRespir Res. 2017.
  9. Virender P. Singh Rathod, Prem Kapoor, K. K. Pillai, and Razia Khanam, Assessment of asthma and chronic obstructive pulmonary disorder in relation to reversibility, IgE, eosinophil, and neutrophil count in a University Teaching Hospital in South Delhi, India.
  10. Singh B1, Arora S, Khanna V. Association of severity of COPD with IgE and interleukin-1 beta. Monaldi Arch Chest Dis. 2010 Jun;73(2):86-7.

Corresponding Author

K.A. Vivek